CY2009005I1 - Συνεργιστικοι συνδυασμοι που περιλαμβανουν αναστολεα ρενινης για καρδιαγγειακες παθησεις - Google Patents

Συνεργιστικοι συνδυασμοι που περιλαμβανουν αναστολεα ρενινης για καρδιαγγειακες παθησεις

Info

Publication number: CY2009005I1
Authority: CY; Cyprus
Prior art keywords: cardiovascular disease; combinations including; renin inhibitor; synergic combinations; synergic
Prior art date: 2000-11-17

Application number

CY2009005C

Other languages

English (en)

Other versions

CY2009005I2 (el

Original Assignee

Novartis Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-17

Filing date

2009-05-11

Publication date

2012-01-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9903412&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2009005(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-05-11 Application filed by Novartis Pharma Ag filed Critical Novartis Pharma Ag

2012-01-25 Publication of CY2009005I1 publication Critical patent/CY2009005I1/el

2012-01-25 Publication of CY2009005I2 publication Critical patent/CY2009005I2/el

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Child & Adolescent Psychology (AREA)
Toxicology (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Hydrogenated Pyridines (AREA)

CY2009005C 2000-11-17 2009-05-11 Συνεργιστικοι συνδυασμοι που περιλαμβανουν αναστολεα ρενινης για καρδιαγγειακες παθησεις CY2009005I2 (el)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0028151A GB0028151D0 (en)	2000-11-17	2000-11-17	Combination of organic compounds
PCT/EP2001/013241 WO2002040007A1 (en)	2000-11-17	2001-11-15	Synergistic combinations comprising a renin inhibitor for cardiovascular diseases

Publications (2)

Publication Number	Publication Date
CY2009005I1 true CY2009005I1 (el)	2012-01-25
CY2009005I2 CY2009005I2 (el)	2012-01-25

Family

ID=9903412

Family Applications (5)

Application Number	Title	Priority Date	Filing Date
CY20061100519T CY1105603T1 (el)	2000-11-17	2006-04-13	Συνεργιστικοι συνδυασμοι που περιλαμβανουν εναν αναστολεα της ρενινης, για καρδιαγγειακες νοσους
CY20081100932T CY1108305T1 (el)	2000-11-17	2008-09-02	Συνεργιστικοι συνδυασμοι που περιλαμβανουν αναστολεα ρενινης για καρδιαγγειακες παθησεις
CY2009005C CY2009005I2 (el)	2000-11-17	2009-05-11	Συνεργιστικοι συνδυασμοι που περιλαμβανουν αναστολεα ρενινης για καρδιαγγειακες παθησεις
CY20131100889T CY1114829T1 (el)	2000-11-17	2013-10-10	Συνεργιστικοι συνδυασμοι που περιλαμβανουν αναστολεα ρενινης για καρδιαγγειακες παθησεις
CY2013045C CY2013045I1 (el)	2000-11-17	2013-12-13	Συνεργιστικοι συνδυασμοι που περιλαμβανουν αναστολεα ρενινης για καρδιαγγειακες παθησεις

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
CY20061100519T CY1105603T1 (el)	2000-11-17	2006-04-13	Συνεργιστικοι συνδυασμοι που περιλαμβανουν εναν αναστολεα της ρενινης, για καρδιαγγειακες νοσους
CY20081100932T CY1108305T1 (el)	2000-11-17	2008-09-02	Συνεργιστικοι συνδυασμοι που περιλαμβανουν αναστολεα ρενινης για καρδιαγγειακες παθησεις

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
CY20131100889T CY1114829T1 (el)	2000-11-17	2013-10-10	Συνεργιστικοι συνδυασμοι που περιλαμβανουν αναστολεα ρενινης για καρδιαγγειακες παθησεις
CY2013045C CY2013045I1 (el)	2000-11-17	2013-12-13	Συνεργιστικοι συνδυασμοι που περιλαμβανουν αναστολεα ρενινης για καρδιαγγειακες παθησεις

Country Status (31)

Country	Link
US (4)	US8168616B1 (el)
EP (7)	EP1341533B1 (el)
JP (6)	JP2004513920A (el)
KR (6)	KR20080096715A (el)
CN (4)	CN101091703A (el)
AT (2)	ATE397445T1 (el)
AU (2)	AU2368002A (el)
BR (1)	BR0115411A (el)
CA (2)	CA2763223A1 (el)
CY (5)	CY1105603T1 (el)
CZ (2)	CZ305341B6 (el)
DE (3)	DE60117295T2 (el)
DK (3)	DK1915993T3 (el)
EC (1)	ECSP034603A (el)
ES (4)	ES2429292T3 (el)
GB (1)	GB0028151D0 (el)
HU (2)	HU230882B1 (el)
IL (3)	IL155707A (el)
LU (2)	LU91563I2 (el)
MX (1)	MXPA03004358A (el)
NL (2)	NL300385I1 (el)
NO (2)	NO334002B1 (el)
NZ (6)	NZ550898A (el)
PL (3)	PL400915A1 (el)
PT (3)	PT1602370E (el)
RU (2)	RU2310443C2 (el)
SG (1)	SG135969A1 (el)
SI (3)	SI1602370T1 (el)
SK (1)	SK287881B6 (el)
WO (1)	WO2002040007A1 (el)
ZA (1)	ZA200303497B (el)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002363087A1 (en) *	2001-10-18	2003-05-06	Novartis Ag	Salts formed of an at1-receptor antagonist and a cardiovascular agent
WO2003097098A1 (en)	2002-05-17	2003-11-27	Novartis Ag	Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
GB0212410D0 (en)	2002-05-29	2002-07-10	Novartis Ag	Organic compounds
AU2003255527A1 (en) *	2002-06-28	2004-01-19	Speedel Pharma Ag	Pharmaceutical formulation comprising non-peptide renin inhibitor and surfactant
AU2003250858A1 (en) *	2002-06-28	2004-01-19	Novartis Ag	Use of organic compounds
SE0300988D0 (sv) *	2003-04-03	2003-04-03	Astrazeneca Ab	New use
TW200900399A (en)	2003-10-01	2009-01-01	Speedel Experimenta Ag	Organic compounds
GB0325605D0 (en) *	2003-11-03	2003-12-10	Novartis Ag	Combination of organic compounds
CA2600973C (en)	2003-11-26	2012-08-07	Novartis Ag	.delta.-amino-.gamma.-hydroxy-.omega.-aryl-alkanoic acid
GB0327839D0 (en) *	2003-12-01	2003-12-31	Novartis Ag	Organic compounds
AR047447A1 (es) *	2004-01-23	2006-01-18	Speedel Experimenta Ag	Compuestos derivados de amino alcohol con actividad inhibidora de la renina y su uso en composiciones farmaceuticas.
US7767690B2 (en)	2004-01-23	2010-08-03	Novartis Ag	Amino alcohol derivatives and their use as renin inhibitor
ES2357585T3 (es) *	2004-01-23	2011-04-27	Novartis Ag	Derivados de aminoalcoholes y su actividad como inhibidores de la renina.
NZ549535A (en) *	2004-03-17	2010-11-26	Novartis Ag	Use of aliskiren for treating renal and other disorders
AR048431A1 (es)	2004-03-17	2006-04-26	Novartis Ag	Formulaciones galenicas de compuestos organicos
WO2005090304A1 (en) *	2004-03-19	2005-09-29	Speedel Experimenta Ag	Organic compounds
WO2005099695A1 (en) *	2004-04-19	2005-10-27	Novartis Ag	Drug delivery systems for the prevention and treatment of vascular diseases
MX2007004020A (es) *	2004-10-08	2007-05-24	Novartis Ag	Uso de inhibidores de renina para la prevencion o tratamiento de disfuncion diastolica o falla cardiaca diastolica.
GB0428250D0 (en) *	2004-12-23	2005-01-26	Novartis Ag	Organic compounds
MY146830A (en) *	2005-02-11	2012-09-28	Novartis Ag	Combination of organic compounds
EP1897879A3 (en)	2005-03-31	2008-06-11	Speedel Experimenta AG	2,4,5-substituted piperidines as renin inhibitors
TW200722424A (en)	2005-03-31	2007-06-16	Speedel Experimenta Ag	Substituted piperidines
BRPI0609915A2 (pt) *	2005-04-27	2010-05-25	Novartis Ag	métodos para tratar aterosclerose
GB0511686D0 (en) *	2005-06-08	2005-07-13	Novartis Ag	Organic compounds
CN1732952B (zh) *	2005-09-02	2010-04-07	姚俊华	一种治疗高血压的复方分散片
US8158146B2 (en)	2005-09-28	2012-04-17	Teva Pharmaceutical Industries Ltd.	Stable combinations of amlodipine besylate and benazepril hydrochloride
DE602005005706T2 (de) *	2005-09-28	2009-04-16	Teva Pharmaceutical Industries Ltd.	Stabile Arzneimittelkombinationen von Amlodipinbesylat und Benazeprilhydrochlorid
US20080261958A1 (en) *	2005-11-08	2008-10-23	Randy Lee Webb	Combination of Organic Compounds
AR057882A1 (es)	2005-11-09	2007-12-26	Novartis Ag	Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
CA2646438A1 (en) *	2006-03-13	2007-09-20	Encysive Pharmaceuticals, Inc.	Methods and compositions for treatment of diastolic heart failure
US20070260203A1 (en) *	2006-05-04	2007-11-08	Allergan, Inc.	Vasoactive agent intraocular implant
GB0612540D0 (en)	2006-06-23	2006-08-02	Novartis Ag	Galenical formulations of organic compounds
TW200831463A (en) *	2006-09-12	2008-08-01	Speedel Experimenta Ag	Nitrate esters of aminoalcohols
KR100888131B1 (ko) *	2006-10-10	2009-03-11	한올제약주식회사	시간차 투약 원리를 이용한 심혈관계 질환 치료용 복합제제
MX2009006340A (es) *	2006-12-15	2009-06-23	Novartis Ag	Metodos terapeuticos.
CA2677822A1 (en) *	2007-02-14	2008-08-21	Gilead Colorado, Inc.	Antihypertensive drug combination
CL2008002829A1 (es) *	2007-09-28	2009-06-26	Novartis Ag	Combinacion farmaceutica de dosis oral fija que comprende aliskireno y valsartan; uso de la combinacion para tratar hipertension, angina, infarto al miocardio, arterioscleosis, nefropatia diabetica, insuficiencia renal, entre otras; metodos de preparacion de la combinacion en forma de bicapa y en forma se tableta sobre encapsulada.
EP2062874B1 (en)	2007-11-20	2014-12-17	KRKA, tovarna zdravil, d.d., Novo mesto	Process and intermediates for the preparation of aliskiren
US20110111021A1 (en)	2008-02-22	2011-05-12	Hanall Biopharma Co., Ltd.	Pharmaceutical preparation
EP2275093A2 (en)	2008-04-10	2011-01-19	HanAll Biopharma Co., Ltd.	Pharmaceutical formulation
WO2009127251A1 (en) *	2008-04-16	2009-10-22	Novartis Ag	Combinations comprising a renin inhibitor
US20110117194A1 (en)	2008-04-29	2011-05-19	Hanall Biopharma Co., Ltd.	Pharmaceutical formulation containing angiotensin-ii receptor blocker
WO2010024772A1 (en) *	2008-08-29	2010-03-04	Medivir Ab	Aspartyl protease inhibitors
EP2189442B1 (en)	2008-11-20	2014-10-01	Krka Tovarna Zdravil, D.D., Novo Mesto	Process and intermediates for the preparation of aliskiren
MX2011009846A (es)	2009-03-20	2011-09-29	Novartis Ag	Formulaciones galenicas de una combinacion de dosis fija de valsartan y alisquireno.
CN101926793B (zh) *	2010-08-05	2012-08-15	成都自豪药业有限公司	一种含替米沙坦和阿利吉伦的联合用药物及其制备方法
US20140107170A1 (en)	2011-05-06	2014-04-17	Miso Sabovic	Composition comprising angiotensin ii receptor antagonist and antioxidant for maintaining and/or improving skin properties
RU2483750C1 (ru) *	2012-03-19	2013-06-10	Общество с ограниченной ответственностью "СупраГен"	Способ лечения больных с острым инфарктом миокарда с подъемом сегмента st
EP3682902A1 (en) *	2012-05-18	2020-07-22	Luoda Pharma Limited	Liquid formulation
RU2554815C1 (ru) *	2014-06-18	2015-06-27	Общество с ограниченной ответственностью "Нанолек"	Гипотензивное средство
AU2015295845B2 (en)	2014-07-30	2020-03-05	Merck Patent Gmbh	Directly compressible polyvinyl alcohols
SG11201903803UA (en) *	2016-10-27	2019-05-30	Damian Pharma Ag	Aldosterone synthase inhibitor

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4889861A (en)	1982-12-21	1989-12-26	Ciba-Geigy Corp.	Substituted imidazo[1,5-a]pyridine derivatives and other substituted bicyclic derivatives and their use as aromatase inhibitors
US4617307A (en)	1984-06-20	1986-10-14	Ciba-Geigy Corporation	Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US4559332A (en)	1983-04-13	1985-12-17	Ciba Geigy Corporation	20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof
US4782043A (en)	1983-06-15	1988-11-01	Merck & Co., Inc.	Renin inhibitors containing a C-terminal amide cycle
US4898729A (en)	1983-12-09	1990-02-06	Euroceltique, S.A.	Treatment of hypertension, compounds and compositions for antihypertension and diuresis
US4812442A (en)	1984-05-29	1989-03-14	Merck & Co., Inc.	Tripeptide renin inhibitors
CA1334092C (en)	1986-07-11	1995-01-24	David John Carini	Angiotensin ii receptor blocking imidazoles
US5594021A (en)	1993-05-20	1997-01-14	Texas Biotechnology Corporation	Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
US4927807A (en)	1987-10-06	1990-05-22	Abbott Laboratories	Glaucoma treatment
SE8802428D0 (sv) *	1988-06-28	1988-06-28	Haessle Ab	New compounds
US5268374A (en)	1988-10-04	1993-12-07	Abbott Laboratories	Non-peptide renin inhibitors
US5164388A (en)	1988-10-19	1992-11-17	Abbott Laboratories	Heterocyclic peptide renin inhibitors
EP0403159B1 (en)	1989-06-14	2000-03-01	Smithkline Beecham Corporation	Imidazolyl-alkenoic acids
EP0438311A3 (en) *	1990-01-19	1992-07-01	Merck & Co. Inc.	Di- and tripeptide renin inhibitors
US5182266A (en) *	1990-01-31	1993-01-26	Abbott Laboratories	Method for treating renal disease
DE122010000024I1 (de) *	1990-02-19	2010-07-08	Novartis Ag	Acylverbindungen
TW201738B (el)	1990-03-20	1993-03-11	Sanofi Co
US5196444A (en)	1990-04-27	1993-03-23	Takeda Chemical Industries, Ltd.	1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
IE68045B1 (en)	1990-05-11	1996-05-15	Abbott Lab	Renin inhibitors
DK0527879T3 (da) *	1990-05-11	1997-07-14	Pfizer	Synergistiske terapeutiske præparater og fremgangsmåder.
US5821232A (en)	1990-05-11	1998-10-13	Pfizer Inc.	Synergistic therapeutic compositions and methods
WO1992000972A1 (en)	1990-07-11	1992-01-23	Abbott Laboratories	Renin inhibiting compounds
JPH06500111A (ja) *	1990-08-15	1994-01-06	アボツト・ラボラトリーズ	レニン阻害剤
US5656650A (en) *	1990-12-14	1997-08-12	Smithkline Beecham Corp.	Angiotensin II receptor blocking compositions
ATE177634T1 (de) *	1990-12-14	1999-04-15	Smithkline Beecham Corp	Angiotensin-ii-rezeptor blockierende zusammensetzungen
EP0498361A3 (en)	1991-02-06	1992-09-02	Schering Corporation	Combination of an angiotensin ii antagonist or renin inhibitor with a neutral endopeptidase inhibitor
IE920540A1 (en)	1991-02-21	1992-08-26	Sankyo Co	1-biphenylmethylimidazole derivatives, their preparation and¹their therapetuic use
RU2086544C1 (ru)	1991-06-13	1997-08-10	Хоффманн-Ля Рош АГ	Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
DE4121975A1 (de)	1991-07-03	1993-01-07	Basf Ag	Thermoplastische formmassen auf der basis von polycarbonaten, styrol/acrylnitril-polymerisaten und polyolefinen
US5256667A (en) *	1991-09-25	1993-10-26	Merck & Co., Inc.	Quinazolinones and pyridopyrimidinones
TW226375B (el)	1991-10-24	1994-07-11	American Home Prod
US6057344A (en)	1991-11-26	2000-05-02	Sepracor, Inc.	Methods for treating hypertension, and angina using optically pure (-) amlodipine
SG49667A1 (en)	1993-04-27	1998-06-15	Smithkline Beecham Corp	Endothelin receptor antagonists
US5508272A (en)	1993-06-15	1996-04-16	Bristol-Myers Squibb Company	Compounds containing a fused bicycle ring and processes therefor
DK0634175T3 (da) *	1993-07-15	2001-04-30	Hoffmann La Roche	Farmaceutisk kombination, der indeholder en hæmmer af renin-angiotensin-systemet og en endothelin-antagonist
ES2156157T3 (es)	1993-08-18	2001-06-16	Banyu Pharma Co Ltd	Derivado de ciclopenteno heteroaromatico fusionado con una actividad antagonista de la endotelina.
MY119161A (en)	1994-04-18	2005-04-30	Novartis Ag	Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
US5606078A (en)	1994-04-18	1997-02-25	Ciba-Geigy Corporation	3,5-Disubstituted tetrahydrofuran-2-ones
US5659065A (en)	1994-04-18	1997-08-19	Novartis Corporation	Alpha-aminoalkanoic acids and reduction products
US5562921A (en)	1994-07-15	1996-10-08	Sherman; Bernard C.	Stable solid pharmaceutical compositions containing enalapril maleate
WO1996006095A1 (en)	1994-08-19	1996-02-29	Abbott Laboratories	Endothelin antagonists
US5612359A (en)	1994-08-26	1997-03-18	Bristol-Myers Squibb Company	Substituted biphenyl isoxazole sulfonamides
DE19533023B4 (de)	1994-10-14	2007-05-16	Basf Ag	Neue Carbonsäurederivate, ihre Herstellung und Verwendung
TW313568B (el)	1994-12-20	1997-08-21	Hoffmann La Roche
DE69609812D1 (de)	1995-01-27	2000-09-21	Rhone Poulenc Rorer Ltd	Substituierte phenylverbindungen als endothelinantagoniste
US5846990A (en)	1995-07-24	1998-12-08	Bristol-Myers Squibb Co.	Substituted biphenyl isoxazole sulfonamides
JPH0971586A (ja) *	1995-09-07	1997-03-18	Yamanouchi Pharmaceut Co Ltd	新規な二環性縮合イミダゾール誘導体
US5696166A (en)	1995-10-31	1997-12-09	Yanni; John M.	Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
TW414792B (en)	1995-12-20	2000-12-11	Yamanouchi Pharma Co Ltd	An arylethensulfonamide derivative having endothelin receptor antagonistic effect and its pharmaceutical composition
IT1277737B1 (it)	1995-12-28	1997-11-12	Zambon Spa	Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
AU1319697A (en)	1996-01-23	1997-08-20	Shionogi & Co., Ltd.	Process for producing oleanolic acid analogs by culturing hairy root
UA50761C2 (uk)	1996-04-04	2002-11-15	Банью Фармасьютікал Ко., Лтд.	Спосіб запобігання та/або лікування серцевих захворювань, фармацевтична композиція та спосіб запобігання та/або лікування серцевої недостатності та дисфункції шлуночків в організмі теплокровної тварини
GB9613470D0 (en)	1996-06-27	1996-08-28	Ciba Geigy Ag	Small solid oral dosage form
GT199800126A (es) *	1997-08-29	2000-01-29		Terapia de combinacion.
DE19806438A1 (de) *	1998-02-17	1999-08-19	Basf Ag	Neue Carbonsäurederivate mit 5-substituiertem Pyrimidinring, ihre Herstellung und Verwendung
US6248729B1 (en) *	1998-06-17	2001-06-19	Bristol-Myers Squibb Co.	Combination of an ADP-receptor blocking antiplatelet drug and antihypertensive drug and a method for preventing a cerebral infarction employing such combination
AU763309B2 (en)	1998-07-20	2003-07-17	Smithkline Beecham Corporation	Bioenhanced formulations comprising eprosartan in oral solid dosage form
UA74141C2 (uk) *	1998-12-09	2005-11-15	Дж.Д. Сірл Енд Ко.	Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
WO2000056403A1 (en) *	1999-03-19	2000-09-28	The Brigham And Women's Hospital, Inc.	UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
ES2288487T3 (es)	1999-11-09	2008-01-16	Pharmacia Corporation	Uso de eplerenona para tratamiento de la restenosis.
US20030114389A1 (en) *	2001-11-13	2003-06-19	Webb Randy Lee	Combination of organic compounds
WO2003097098A1 (en)	2002-05-17	2003-11-27	Novartis Ag	Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
WO2004059136A1 (de)	2002-12-31	2004-07-15	Volkswagen Aktiengesellschaft	Verfahren zur steuerung einer verbrennungskraftmaschine sowie magerlauffähige verbrennungskraftmaschine

2000
- 2000-11-15 US US10/416,039 patent/US8168616B1/en not_active Expired - Fee Related
- 2000-11-17 GB GB0028151A patent/GB0028151D0/en not_active Ceased
2001
- 2001-11-15 PT PT05015603T patent/PT1602370E/pt unknown
- 2001-11-15 CN CNA200710140212XA patent/CN101091703A/zh active Pending
- 2001-11-15 CN CNA2008100985065A patent/CN101264073A/zh active Pending
- 2001-11-15 CZ CZ2011-614A patent/CZ305341B6/cs not_active IP Right Cessation
- 2001-11-15 ES ES08002401T patent/ES2429292T3/es not_active Expired - Lifetime
- 2001-11-15 SK SK584-2003A patent/SK287881B6/sk not_active IP Right Cessation
- 2001-11-15 CA CA 2763223 patent/CA2763223A1/en not_active Withdrawn
- 2001-11-15 PT PT08002401T patent/PT1915993E/pt unknown
- 2001-11-15 SI SI200130850T patent/SI1602370T1/sl unknown
- 2001-11-15 JP JP2002542381A patent/JP2004513920A/ja not_active Withdrawn
- 2001-11-15 EP EP20010996377 patent/EP1341533B1/en not_active Expired - Lifetime
- 2001-11-15 DE DE2001617295 patent/DE60117295T2/de not_active Expired - Lifetime
- 2001-11-15 HU HUP1400409A patent/HU230882B1/hu not_active IP Right Cessation
- 2001-11-15 ES ES05015603T patent/ES2308347T3/es not_active Expired - Lifetime
- 2001-11-15 PT PT01996377T patent/PT1341533E/pt unknown
- 2001-11-15 EP EP20100179101 patent/EP2305231A1/en not_active Withdrawn
- 2001-11-15 KR KR1020087024051A patent/KR20080096715A/ko not_active Withdrawn
- 2001-11-15 KR KR1020117012347A patent/KR101258365B1/ko not_active Expired - Fee Related
- 2001-11-15 AU AU2368002A patent/AU2368002A/xx active Pending
- 2001-11-15 NZ NZ550898A patent/NZ550898A/en not_active IP Right Cessation
- 2001-11-15 DK DK08002401T patent/DK1915993T3/da active
- 2001-11-15 BR BR0115411A patent/BR0115411A/pt not_active Application Discontinuation
- 2001-11-15 KR KR1020087001407A patent/KR20080011355A/ko not_active Ceased
- 2001-11-15 EP EP20080002604 patent/EP1930000A1/en not_active Withdrawn
- 2001-11-15 SI SI200131026T patent/SI1915993T1/sl unknown
- 2001-11-15 AU AU2002223680A patent/AU2002223680B2/en not_active Expired
- 2001-11-15 DK DK01996377T patent/DK1341533T3/da active
- 2001-11-15 PL PL40091501A patent/PL400915A1/pl unknown
- 2001-11-15 ES ES01996377T patent/ES2256335T3/es not_active Expired - Lifetime
- 2001-11-15 DE DE200912000021 patent/DE122009000021I1/de active Pending
- 2001-11-15 NZ NZ537691A patent/NZ537691A/en not_active IP Right Cessation
- 2001-11-15 SI SI200130530T patent/SI1341533T1/sl unknown
- 2001-11-15 CA CA 2428647 patent/CA2428647A1/en not_active Withdrawn
- 2001-11-15 DE DE60134349T patent/DE60134349D1/de not_active Expired - Lifetime
- 2001-11-15 IL IL155707A patent/IL155707A/en not_active IP Right Cessation
- 2001-11-15 KR KR10-2003-7005901A patent/KR20030051753A/ko not_active Ceased
- 2001-11-15 AT AT05015603T patent/ATE397445T1/de active
- 2001-11-15 CZ CZ20031341A patent/CZ299749B6/cs not_active IP Right Cessation
- 2001-11-15 MX MXPA03004358A patent/MXPA03004358A/es active IP Right Grant
- 2001-11-15 EP EP20080002401 patent/EP1915993B1/en not_active Revoked
- 2001-11-15 PL PL40091401A patent/PL400914A1/pl unknown
- 2001-11-15 RU RU2003116896A patent/RU2310443C2/ru not_active IP Right Cessation
- 2001-11-15 KR KR1020107018819A patent/KR20100114904A/ko not_active Ceased
- 2001-11-15 WO PCT/EP2001/013241 patent/WO2002040007A1/en not_active Ceased
- 2001-11-15 ES ES10179109T patent/ES2734523T3/es not_active Expired - Lifetime
- 2001-11-15 HU HU0301841A patent/HUP0301841A3/hu not_active Application Discontinuation
- 2001-11-15 EP EP20050015603 patent/EP1602370B1/en not_active Revoked
- 2001-11-15 NZ NZ525795A patent/NZ525795A/en not_active IP Right Cessation
- 2001-11-15 SG SG200504685-9A patent/SG135969A1/en unknown
- 2001-11-15 NZ NZ568764A patent/NZ568764A/en not_active IP Right Cessation
- 2001-11-15 AT AT01996377T patent/ATE317692T1/de active
- 2001-11-15 DK DK05015603T patent/DK1602370T3/da active
- 2001-11-15 NZ NZ550897A patent/NZ550897A/en not_active IP Right Cessation
- 2001-11-15 NZ NZ550896A patent/NZ550896A/en not_active IP Right Cessation
- 2001-11-15 EP EP20100179116 patent/EP2305233A1/en not_active Withdrawn
- 2001-11-15 CN CNA2008100985050A patent/CN101264072A/zh active Pending
- 2001-11-15 KR KR1020087024052A patent/KR101008752B1/ko not_active Expired - Fee Related
- 2001-11-15 PL PL361404A patent/PL227576B1/pl unknown
- 2001-11-15 CN CNB018190685A patent/CN100404024C/zh not_active Expired - Fee Related
- 2001-11-15 EP EP10179109.3A patent/EP2305232B1/en not_active Expired - Lifetime
2003
- 2003-05-07 ZA ZA200303497A patent/ZA200303497B/en unknown
- 2003-05-13 EC ECSP034603 patent/ECSP034603A/es unknown
- 2003-05-16 NO NO20032233A patent/NO334002B1/no not_active IP Right Cessation
2006
- 2006-04-13 CY CY20061100519T patent/CY1105603T1/el unknown
- 2006-09-12 RU RU2006132668A patent/RU2346703C2/ru not_active IP Right Cessation
2008
- 2008-09-02 CY CY20081100932T patent/CY1108305T1/el unknown
2009
- 2009-04-24 NL NL300385C patent/NL300385I1/nl unknown
- 2009-05-06 LU LU91563C patent/LU91563I2/fr unknown
- 2009-05-11 CY CY2009005C patent/CY2009005I2/el unknown
- 2009-07-22 JP JP2009171142A patent/JP2009235107A/ja not_active Withdrawn
2011
- 2011-03-31 IL IL212075A patent/IL212075A/en not_active IP Right Cessation
- 2011-09-19 US US13/235,758 patent/US9023894B2/en not_active Expired - Fee Related
- 2011-09-19 US US13/235,659 patent/US9023893B2/en not_active Expired - Fee Related
- 2011-09-19 US US13/235,787 patent/US8618174B2/en not_active Expired - Fee Related
2012
- 2012-01-30 IL IL217847A patent/IL217847A0/en unknown
2013
- 2013-07-17 JP JP2013148269A patent/JP6089278B2/ja not_active Expired - Lifetime
- 2013-10-10 CY CY20131100889T patent/CY1114829T1/el unknown
- 2013-11-27 LU LU92315C patent/LU92315I2/fr unknown
- 2013-12-13 CY CY2013045C patent/CY2013045I1/el unknown
- 2013-12-17 NO NO2013019C patent/NO2013019I1/no unknown
2016
- 2016-11-01 JP JP2016214552A patent/JP6373931B2/ja not_active Expired - Lifetime
2017
- 2017-12-04 JP JP2017232474A patent/JP6577994B2/ja not_active Expired - Lifetime
2018
- 2018-05-30 JP JP2018103151A patent/JP6603757B2/ja not_active Expired - Lifetime
2019
- 2019-09-06 NL NL301005C patent/NL301005I2/nl unknown

Also Published As

Publication number	Publication date
JP2018030894A (ja)	2018-03-01
CY1114829T1 (el)	2015-11-04
NL301005I1 (el)	2019-09-10
HK1115544A1 (en)	2008-12-05
DK1602370T3 (da)	2008-09-22
IL212075A (en)	2013-08-29
BR0115411A (pt)	2004-08-17
IL155707A (en)	2012-02-29
ES2256335T3 (es)	2006-07-16
EP1602370A2 (en)	2005-12-07
IL217847A0 (en)	2012-03-29
SI1915993T1 (sl)	2013-10-30
KR20100114904A (ko)	2010-10-26
CZ299749B6 (cs)	2008-11-12
DE60134349D1 (de)	2008-07-17
AU2002223680B2 (en)	2005-04-07
JP2009235107A (ja)	2009-10-15
DK1915993T3 (da)	2013-10-14
JP2017019876A (ja)	2017-01-26
EP2305233A1 (en)	2011-04-06
NZ550896A (en)	2008-06-30
PT1915993E (pt)	2013-10-14
HUP0301841A3 (en)	2010-07-28
WO2002040007A1 (en)	2002-05-23
DE60117295D1 (de)	2006-04-20
JP6089278B2 (ja)	2017-03-08
CY2013045I2 (el)	2015-11-04
PL227576B1 (pl)	2017-12-29
RU2310443C2 (ru)	2007-11-20
KR20080096715A (ko)	2008-10-31
ZA200303497B (en)	2004-04-28
DE60117295T2 (de)	2006-08-17
IL212075A0 (en)	2011-06-30
LU92315I2 (fr)	2014-01-27
JP2018131465A (ja)	2018-08-23
HU1400409D0 (hu)	2003-09-29
PT1602370E (pt)	2008-09-10
US9023893B2 (en)	2015-05-05
SG135969A1 (en)	2007-10-29
US20120004312A1 (en)	2012-01-05
ECSP034603A (es)	2003-06-25
NO2013019I2 (no)	2013-12-17
EP1602370B1 (en)	2008-06-04
PL400914A1 (pl)	2012-12-17
NL300385I1 (nl)	2009-07-01
GB0028151D0 (en)	2001-01-03
CY1108305T1 (el)	2012-01-25
EP1930000A1 (en)	2008-06-11
EP2305231A1 (en)	2011-04-06
CN100404024C (zh)	2008-07-23
RU2006132668A (ru)	2008-03-20
LU91563I2 (fr)	2009-07-06
PL400915A1 (pl)	2012-12-17
SK5842003A3 (en)	2003-11-04
EP2305232A1 (en)	2011-04-06
KR20030051753A (ko)	2003-06-25
CY2009005I2 (el)	2012-01-25
CA2763223A1 (en)	2002-05-23
CN1474690A (zh)	2004-02-11
EP1915993A1 (en)	2008-04-30
NL301005I2 (nl)	2019-10-29
NZ537691A (en)	2007-01-26
DE122009000021I1 (de)	2009-08-06
HK1059212A1 (en)	2004-06-25
EP2305232B1 (en)	2019-07-17
HUP0301841A2 (hu)	2003-09-29
JP6577994B2 (ja)	2019-09-18
NZ550898A (en)	2008-07-31
NO20032233L (no)	2003-05-16
SI1341533T1 (sl)	2006-08-31
NO334002B1 (no)	2013-11-11
KR20080011355A (ko)	2008-02-01
US9023894B2 (en)	2015-05-05
EP1341533B1 (en)	2006-02-15
CZ305341B6 (cs)	2015-08-05
NO2013019I1 (no)	2014-06-02
CN101091703A (zh)	2007-12-26
HU230882B1 (hu)	2018-11-29
NZ568764A (en)	2009-11-27
EP1341533A1 (en)	2003-09-10
KR101258365B1 (ko)	2013-04-30
AU2368002A (en)	2002-05-27
CY1105603T1 (el)	2010-07-28
JP6603757B2 (ja)	2019-11-06
NO20032233D0 (no)	2003-05-16
PT1341533E (pt)	2006-06-30
US8618174B2 (en)	2013-12-31
ATE317692T1 (de)	2006-03-15
ES2429292T3 (es)	2013-11-14
SK287881B6 (sk)	2012-02-03
RU2346703C2 (ru)	2009-02-20
EP1602370A3 (en)	2005-12-14
IL155707A0 (en)	2003-11-23
DK1341533T3 (da)	2006-05-08
KR20110063596A (ko)	2011-06-10
US8168616B1 (en)	2012-05-01
JP2004513920A (ja)	2004-05-13
CY2013045I1 (el)	2015-11-04
US20120016035A1 (en)	2012-01-19
EP1915993B1 (en)	2013-07-10
ATE397445T1 (de)	2008-06-15
JP2013213061A (ja)	2013-10-17
CN101264072A (zh)	2008-09-17
ES2734523T3 (es)	2019-12-10
PL361404A1 (en)	2004-10-04
NZ525795A (en)	2005-03-24
CA2428647A1 (en)	2002-05-23
SI1602370T1 (sl)	2008-10-31
ES2308347T3 (es)	2008-12-01
US20120010295A1 (en)	2012-01-12
MXPA03004358A (es)	2003-08-19
KR20080097488A (ko)	2008-11-05
NZ550897A (en)	2008-03-28
KR101008752B1 (ko)	2011-01-14
CN101264073A (zh)	2008-09-17
HK1089356A1 (en)	2006-12-01
JP6373931B2 (ja)	2018-08-15

Publication	Publication Date	Title
CY2013045I1 (el)	2015-11-04	Συνεργιστικοι συνδυασμοι που περιλαμβανουν αναστολεα ρενινης για καρδιαγγειακες παθησεις
IS6601A (is)	2002-10-29	Sýklópentýl-setnar glútaramíðafleiður sem hindrarhlutlausra endópeptíðasa
IS6714A (is)	2003-02-11	Fjölbrigði epóþílon hliðstæðu
ATE524441T1 (de)	2011-09-15	Vla-4-inhibitoren
AU8560101A (en)	2002-03-22	Multivalent neuraminidase inhibitor conjugates
NO20016319L (no)	2002-02-28	VLA-4 inhibitor-forbindelser
DE60123294D1 (de)	2006-11-02	Diazepan Derivate als Faktor X Inhibitor
NO20023261D0 (no)	2002-07-05	Småbok
FI20000369L (fi)	2001-08-18	Menetelmä kefalokuvauksen suorittamiseksi
DK1292736T3 (da)	2005-02-14	Indlöbssæt til en cisterne
DE60126877D1 (de)	2007-04-12	D/A-Wandler
DE60031109D1 (de)	2006-11-16	Übertragsicherstellungsaddierer
FR2811262B1 (fr)	2004-07-09	Grattoir a chasse-clous
FR2848281B1 (fr)	2007-04-27	Robinet a boisseau
ITMI20000286V0 (it)	2000-05-10	Frigorifero a ripiani parzialmente estraibili
NO20024611D0 (no)	2002-09-26	Fremgangsmåte for å profilbestemme et planteekstrakt
DK200100180U3 (da)	2001-08-24	Nedgangsbrønd
DE50010748D1 (de)	2005-08-25	Rotationsunabhängige Betätigung eines Maschinenteils
DE60139327D1 (de)	2009-09-03	Lademechanismus eines plattenabspielgeräts
ITMN20000012A0 (it)	2000-03-06	Caldaia a legna
NO20025654D0 (no)	2002-11-25	Anordning ved en seng
FR2790057B1 (fr)	2002-01-04	Coupleur a billes
ITMI20010368V0 (it)	2001-07-03	Cartoncino per gioco a coppie
IT250521Y1 (it)	2003-09-24	Puntello a crocera multiuso
NO20000719D0 (no)	2000-02-14	Strupeventil